Tango Therapeutics Inc
NASDAQ:TNGX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Tango Therapeutics Inc
NASDAQ:TNGX
|
US |
|
Shizuoka Gas Co Ltd
TSE:9543
|
JP |
|
Omni Lite Industries Canada Inc
XTSX:OML
|
US |
|
Bridgepoint Group PLC
LSE:BPT
|
UK |
|
Bristow Group Inc
NYSE:VTOL
|
US |
|
Australian Finance Group Ltd
ASX:AFG
|
AU |
|
Orexo AB
STO:ORX
|
SE |
|
Leo Group Co Ltd
SZSE:002131
|
CN |
|
B
|
BriQ Properties REIC
ATHEX:BRIQ
|
GR |
|
Marcus Corp
NYSE:MCS
|
US |
Wall St Price Targets
TNGX Price Targets Summary
Tango Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for
TNGX is 29.78 USD with a low forecast of 21.21 USD and a high forecast of 42 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is TNGX's stock price target?
Price Target
29.78
USD
According to Wall Street analysts, the average 1-year price target for
TNGX is 29.78 USD with a low forecast of 21.21 USD and a high forecast of 42 USD.
What is the Revenue forecast for Tango Therapeutics Inc?
Projected CAGR
1%
The compound annual growth rate for Revenue over the next 3 years is 1%.